Pfizer’s phase-III Jade trial shows positive results
The trial compares the efficacy of abrocitinib and dupilumab for moderate-to-severe atopic dermatitisa
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.